Predicting psychiatric symptoms in methamphetamine psychosis
Part of Mental health clinical trials.
This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psychosis caused by methamphetamine use.
- You have not taken any psychiatric medications for at least one month before joining.
- You are between 18 and 64 years old.
- You do not have high blood pressure, diabetes, kidney disease, rheumatoid arthritis, lupus, heart disease, or serious neurological disorders.
- You do not have another primary psychiatric condition besides methamphetamine-induced psychosis.
- You do not have an alcohol use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares people who have psychosis from methamphetamine and also use cannabis with those who only have methamphetamine-induced psychosis. It aims to understand how cannabis may affect their symptoms.
This study looks at the electrical activity of the heart (ECG) in people who use methamphetamine, including those who develop psychosis from it. It compares them to healthy volunteers to see if methamphetamine affects heart function.
This study compares people with schizophrenia to people whose psychosis was caused by methamphetamine use. Researchers will look at how these two groups differ, which may help improve diagnosis and treatment.
This trial tests whether psilocybin, a psychedelic substance, can help people with moderate to severe methamphetamine use disorder reduce or stop their use. It may work by helping the brain reset, but it's not a standard treatment and involves careful monitoring.
This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
Hear when a new Methamphetamine Induced Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.